AC Immune S.A. Stock Analysis & AI Score
AC Immune S.A. (ACIU) has an ST Score of 42.9 (C), driven by its Forecast (A) and held back by its Financial Strength (F). Analysts rate it Buy with a $8.33 price target (+213.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
AC Immune S.A. (ACIU) has an ST Score of 42.9 (C), driven by its Forecast (A) and held back by its Financial Strength (F). Analysts rate it Buy with a $8.33 price target (+213.2% upside).
- Strongest
- ForecastA
- Weakest
- Financial StrengthF
All factor grades
- ForecastA
- GrowthB+
- MomentumB-
- SentimentC+
- ValuationC
- ProfitabilityD+
- Financial StrengthF
- Piotroski2/9
Contact
ACIU stock: frequently asked questions
What is ACIU's ST Score?
AC Immune S.A. (ACIU) has an ST Score of 42.9 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ACIU a buy, hold, or sell?
Analysts rate ACIU a Buy, with a price target of $8.33 (+213.2% vs the current price). Our ST Score grades it C (42.9/100). The ST Score is a data-driven signal, not a recommendation.
What are ACIU's factor grades?
Valuation C, Profitability D+, Financial Strength F, Momentum B-, Growth B+, Forecast A, Sentiment C+.
What is ACIU's valuation grade?
AC Immune S.A. (ACIU) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ACIU's growth grade?
AC Immune S.A. (ACIU) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ACIU's profitability grade?
AC Immune S.A. (ACIU) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ACIU's financial strength grade?
AC Immune S.A. (ACIU) earns a financial strength grade of F, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ACIU?
The average analyst price target for AC Immune S.A. (ACIU) is $8.33 from 9 analysts, which is +213.2% versus the recent price of $2.66.
What is ACIU's Piotroski score?
AC Immune S.A. (ACIU) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.